Catamount Wealth Management - IMMUNOCELLULAR THERAPEUTICS ownership

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 37 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Catamount Wealth Management ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2016$01,0000.0%0.00%
Q2 2016$01,0000.0%0.00%
Q1 2016$01,0000.0%0.00%
Q4 2015$01,0000.0%0.00%
Q3 2015$01,0000.0%0.00%
Q2 2015$01,0000.0%0.00%
Q1 2015$0
-100.0%
1,0000.0%0.00%
-100.0%
Q4 2014$1,0001,0000.00%
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q2 2016.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders